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Background
Type 2 Diabetes Mellitus (T2DM) is a complex and pleo-
morphic metabolic disorder arising from a complex inter-
action between genes and the environment. However, the
molecular landscape of T2DM is not fully explored,
especially in a highly consanguineous society as the Saudi
Arabian population [1]. Extended families could be pre-
dicted to cause an increase in the number and severity of
genetic susceptibility factors for T2DM. We explore this
hypothesis by applying whole-exome sequencing on four
members of a Saudi family who all suffer from T2DM.
Materials and methods
Whole-exome sequencing of genomic DNA extracted
from peripheral blood is performed on 3 brothers and
their mother who are all suffering from confirmed
T2DM. Sequencing was performed on the SOLiD 5500
XL platform at the Center of Excellence in Genomic
Medicine Research, Jeddah, Saudi Arabia.
Results
We have identified novel mutations affecting SPRY2,
ALPK2, ANXA4, and AGBL2 genes that could affect
this family particularly susceptible to T2DM.
Conclusions
Whole-exome sequencing is very useful tool for detecting
a large fraction of mutations, however, it cannot determine
other genetic aberrations such as copy number and struc-
tural variations. However, finding novel mutations in a
T2DM affecting genes such as SPRY2 may implicate these
genes in diabetes.
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